17 Einträge gefunden

1. From diagnostic tool to disease monitoring: the growing role of prostate biopsies.

   1. Graefen, Markus
   2. Schlomm, Thorsten

   2013 - Forschungsinformationssystem des UKE
2. External validation of the updated Briganti nomogram to predict lymph node invasion in prostate cancer patients undergoing extended lymph node dissection.

   1. Hansen, Jens
   2. Rink, Michael
   3. Bianchi, Marco
   4. Kluth, Luis A
   5. Tian, Zhe
   6. Ahyai, Sascha A
   7. Shariat, Shahrokh F

   2013 - Forschungsinformationssystem des UKE
3. Open and robot-assisted radical retropubic prostatectomy in men receiving ongoing low-dose aspirin medication: revisiting an old paradigm?

   1. Leyh-Bannurah, Sami-Ramzi
   2. Hansen, Jens
   3. Isbarn, Hendrik
   4. Steuber, Thomas
   5. Tennstedt, Pierre
   6. Michl, Uwe
   7. Schlomm, Thorsten

   2013 - Forschungsinformationssystem des UKE
4. High mitochondria content is associated with prostate cancer disease progression

   1. Grupp, Katharina
   2. Jedrzejewska, Karolina
   3. Tsourlakis, Maria Christina
   4. Koop, Christina
   5. Wilczak, Waldemar
   6. Adam, Meike
   7. Quaas, Alexander

   2013 - Forschungsinformationssystem des UKE - frei zugänglich
5. Effect of nodal metastases on cancer-specific mortality after cytoreductive nephrectomy.

   1. Trinh, Quoc-Dien
   2. Sukumar, Shyam
   3. Schmitges, Jan
   4. Bianchi, Marco
   5. Sun, Maxine
   6. Shariat, Shahrokh F
   7. Sammon, Jesse D

   2013 - Forschungsinformationssystem des UKE
6. Assays for prostate cancer: changing the screening paradigm?

   1. Hansen, Jens
   2. Rink, Michael
   3. Graefen, Markus
   4. Shariat, Shahrokh
   5. Chun, Felix K-H

   2013 - Forschungsinformationssystem des UKE
7. CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer

   1. Burkhardt, Lia
   2. Fuchs, Sarah
   3. Krohn, Antje
   4. Masser, Sawinee
   5. Mader, Malte
   6. Kluth, Martina
   7. Bachmann, Frederik

   2013 - Forschungsinformationssystem des UKE
8. Loss of pSer2448-mTOR expression is linked to adverse prognosis and tumor progression in ERG-fusion-positive cancers.

   1. Müller, Juliane
   2. Ehlers, Arne
   3. Burkhardt, Lia
   4. Sirma, Hüseyin
   5. Steuber, Thomas
   6. Graefen, Markus
   7. Sauter, Guido

   2013 - Forschungsinformationssystem des UKE
9. Reduced CD147 expression is linked to ERG fusion-positive prostate cancers but lacks substantial impact on PSA recurrence in patients treated by radical prostatectomy

   1. Grupp, Katharina
   2. Höhne, Thorsten Simon
   3. Prien, Kristina
   4. Hube-Magg, Claudia
   5. Tsourlakis, Maria Christina
   6. Sirma, Hüseyin
   7. Pham, Taher

   2013 - Forschungsinformationssystem des UKE
10. High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers

    1. Grupp, Katharina
    2. Sanader, Stella
    3. Sirma, Hüseyin
    4. Simon, Ronald
    5. Koop, Christina
    6. Prien, Kristina
    7. Hube-Magg, Claudia

    2013 - Forschungsinformationssystem des UKE - frei zugänglich
11. Sociodemographic disparities in the treatment of small renal masses.

    1. Becker, Andreas
    2. Roghmann, Florian
    3. Trinh, Quoc-Dien
    4. Hansen, Jens
    5. Tian, Zhe
    6. Shariat, Shahrokh F
    7. Noldus, Joachim

    2013 - Forschungsinformationssystem des UKE
12. Active surveillance for low-risk prostate cancer: some questions are answered, but many questions remain.

    1. Graefen, Markus
    2. Schlomm, Thorsten

    2013 - Forschungsinformationssystem des UKE
13. Impact of age and comorbidities on long-term survival of patients with high-risk prostate cancer treated with radical prostatectomy: a multi-institutional competing-risks analysis

    1. Briganti, Alberto
    2. Spahn, Martin
    3. Joniau, Steven
    4. Gontero, Paolo
    5. Bianchi, Marco
    6. Kneitz, Burkhard
    7. Chun, Felix K H

    2013 - Forschungsinformationssystem des UKE
14. Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers

    1. Krohn, Antje
    2. Seidel, Annemarie
    3. Burkhardt, Lia
    4. Bachmann, Frederik
    5. Mader, Malte
    6. Grupp, Katharina
    7. Eichenauer, Till

    2013 - Forschungsinformationssystem des UKE
15. Overexpression of the chromatin remodeler death-domain-associated protein in prostate cancer is an independent predictor of early prostate-specific antigen recurrence

    1. Tsourlakis, Maria Christina
    2. Schoop, Michael
    3. Plaß, Christoph
    4. Huland, Hartwig
    5. Graefen, Markus
    6. Steuber, Thomas
    7. Schlomm, Thorsten

    2013 - Forschungsinformationssystem des UKE
16. Marked heterogeneity of ERG expression in large primary prostate cancers.

    1. Minner, Sarah
    2. Gärtner, Michael
    3. Freudenthaler, Fabian
    4. Bauer, Melanie
    5. Kluth, Martina
    6. Salomon, Georg
    7. Heinzer, Hans

    2013 - Forschungsinformationssystem des UKE
17. An analysis of patients with T2 renal cell carcinoma (RCC) according to tumour size: a population-based analysis.

    1. Bianchi, Marco
    2. Becker, Andreas
    3. Trinh, Quoc-Dien
    4. Abdollah, Firas
    5. Tian, Zhe
    6. Shariat, Shahrokh F
    7. Montorsi, Francesco

    2013 - Forschungsinformationssystem des UKE